Bone chondrosarcoma

Summary

Bone chondrosarcoma (MONDO:0000515) is a disease. A subtype of bone cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	bone chondrosarcoma
Mondo ID	MONDO:0000515
DOID	DOID:0050897
UMLS	C3163843
MedGen	756255
GARD	0022784
Anatomy (UBERON)	UBERON:0002481
Is cancer (heuristic)	no

Also known as: bone tissue chondrosarcoma (disease) · chondrosarcoma (disease) of bone tissue

Disease family

This is a subtype of bone cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system cancer › bone cancer › bone chondrosarcoma

Related subtypes (11): skull cancer, bone carcinoma, small cell osteogenic sarcoma, peripheral primitive neuroectodermal tumor of bone, sternum cancer, chest wall bone cancer, adult extraskeletal osteosarcoma, primary bone lymphoma, bone sarcoma, bone marrow cancer, cancer affecting bone of limb skeleton

Subtypes (3): periosteal chondrosarcoma, clear cell chondrosarcoma, dedifferentiated chondrosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.